SAGE CAPITAL ADVISORS,LLC Amicus Therapeutics, Inc. Transaction History

SAGE CAPITAL ADVISORS,LLC portfolio value:

$113,000
portfolio value

SAGE CAPITAL ADVISORS,LLC quarter portfolio value change:

-2.79%
quarter

Amicus Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -5.26% -600 shares -9K $10.44 10.8K
Q2 2022 share Decrease -3.80% -450 shares 19K $10.74 11.4K
Q1 2022 share Increase 0.00% 11.85K shares 103K $9.47 11.85K
Q4 2021 share Decrease -100.00% -10.85K shares -104K $11.67 0
Q3 2021 share Increase 0.00% 10.85K shares 104K $9.55 10.85K
Q1 2020 share Decrease -100.00% -10.2K shares -99K $9.24 0
Q4 2019 share Increase 0.00% 10.2K shares 99K $9.74 10.2K
Q3 2019 share Decrease -100.00% -10.2K shares -135K $8.02 0
Q2 2019 share Decrease -16.39% -2K shares -31K $12.48 10.2K
Q1 2019 share Decrease -1.61% -200 shares 47K $13.6 12.2K
Q4 2018 share Increase +13.76% 1.5K shares -13K $9.58 12.4K
Q3 2018 share Increase +6.86% 700 shares -27K $12.09 10.9K
Q2 2018 share Decrease -4.67% -500 shares -2K $15.62 10.2K
Q1 2018 share Decrease -4.46% -500 shares 0 $15.04 10.7K
Q4 2017 share Increase +9.80% 1K shares 7K $14.39 11.2K
Q3 2017 share Increase 0.00% 10.2K shares 154K $15.08 10.2K